Order results by:
| Issue | Title | |
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... with perindopril (groups 1 and 3, respectively) or carvedilol (groups 2 and 4, respectively). Follow-up was 6 ..." | ||
| Vol 7, No 3 (2011) | COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) | Abstract similar documents |
| S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva | ||
| "... Aim. To compare the efficacy and safety of carvedilol in men and women with mild to moderate ..." | ||
| Vol 5, No 3 (2009) | COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) | Abstract similar documents |
| Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova | ||
| "... and 11 mm Hg respectively. Angina attacks were registered less often in patients of carvedilol group (р=0,001 ..." | ||
| Vol 6, No 4 (2010) | PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov | ||
| "... on carvedilol or metoprolol in patients with arterial hypertension (HT) 1-2 degrees and overweight/obesity ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| "... ,26±0,10kg/m2 (р<0,01) in metoprolol group. Carvedilol in comparison with metoprolol had more positive ..." | ||
| Vol 6, No 4 (2010) | HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD | Abstract PDF (Eng) similar documents |
| A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov | ||
| "... ) received combined therapy with ramipril, carvedilol and trimetazidine. HRV parameters (derived from ECG 5 ..." | ||
| Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
| "... Aim. To evaluate antihypertensive and metabolic effects of the therapy based on carvedilol (C ..." | ||
| Vol 4, No 2 (2008) | BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL | Abstract similar documents |
| A. N. Zakirova, F. S. Zarudij, B. N. Garifullin | ||
| "... drug properties (water repellency, dipole moment, molecular mass). Trail results on carvedilol ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... Aim. To compare antihypertensive and metabolic effects of long-term treatment with carvedilol ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... The review presented the importance of carvedilol using in terms of renoprotection in renal ..." | ||
| Vol 2, No 3 (2006) | HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. I. Markova, A. I. Radzevich | ||
| "... Aim. To evaluate the influence of carvedilol (Talliton, Egis, Hungary) on daily profile of blood ..." | ||
| Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpigina | ||
| "... (EF) of long-term treatment with carvedilol or bisoprolol in patients with arterial hypertension (HT ..." | ||
| Vol 5, No 3 (2009) | EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS | Abstract similar documents |
| A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko | ||
| "... Aim. To study effects of carvedilol and metoprolol on vegetative regulation of heart ..." | ||
| Vol 5, No 4 (2009) | METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER | Abstract similar documents |
| B. N. Garifullin, A. N. Zakirova, F. S. Zarudij | ||
| "... of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... Aim. To evaluate an influence of emcarvedilol/em on risk of hypoglycemia in patients with diabetes type ..." | ||
| Vol 13, No 6 (2017) | THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| A. N. Zakirova, B. N. Garifullin, N. E. Zakirova | ||
| "... in experimental data. emCarvedilol/em is a third-generation beta-blocker with additional pleiotropic and antioxidant ..." | ||
| Vol 4, No 5 (2008) | CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... for comparable study of efficacy and safety of therapies based on β-blockers (emcarvedilol/em and metoprolol ..." | ||
| Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
| O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
| "... Aim. To evaluate influence of the combined therapy with ACE inhibitor (emperindopril/em), diuretic ..." | ||
| Vol 7, No 4 (2011) | PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| "... problems in modern cardiology and nephrology. emPerindopril/em therapy reduces cardiovascular risk in patients ..." | ||
| Vol 9, No 5 (2013) | THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL | Abstract similar documents |
| A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva | ||
| "... Aim. To evaluate the therapeutic equivalence between generic emperindopril/em (Parnavel, LLC Ozone ..." | ||
| Vol 6, No 3 (2010) | ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY | Abstract similar documents |
| V. A. Nevzorova, E. S. Potapova, O. V. Nastradin | ||
| "... Aim. To evaluate an efficacy of the 24-week antihypertensive therapy based on the emcarvedilol/em ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova | ||
| "... . They were randomized in two groups. The first group was presented with 43 patients receiving emcarvedilol/em ..." | ||
| Vol 4, No 2 (2008) | COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
| M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva | ||
| "... Aim. To compare efficacy of emcarvedilol/em and bisoprolol in patients with chronic heart failure (CHF ..." | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| "... emperindopril/em,rosuvastatin and fixed-dose combination of emperindopril/em and indapamide, in ambulatory patients ..." | ||
| Vol 6, No 2 (2010) | EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION | Abstract PDF (Eng) similar documents |
| A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova | ||
| "... Aim. To study influence of beta-blockers emcarvedilol/em and metoprolol tartrate on platelet ..." | ||
| Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
| O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
| "... Aim. To assess efficacy and safety of single-pill combination (SPC) amlodipine/emperindopril/em ..." | ||
| Vol 1, No 3 (2005) | CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL | Abstract similar documents |
| M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina | ||
| "... . The average daily doses were 5,7+0,8 mg for and 32,6+3,4 mg for emcarvedilol/em. The duration of the observation ..." | ||
| Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
| E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
| "... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) emcarvedilols/em with estimation of their serum level. And to study ..." | ||
| Vol 5, No 5 (2009) | EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES | Abstract similar documents |
| O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova | ||
| "... Aim. To evaluate a short-term efficacy and safety of nebivolol and emcarvedilol/em in hypertensive ..." | ||
| Vol 7, No 3 (2011) | COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY | Abstract similar documents |
| O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko | ||
| "... Aim. To compare effects of emperindopril/em and losartan potassium on the parameters of the ambulatory ..." | ||
| Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
| O. M. Drapkina | ||
| "... with emperindopril/em (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid ..." | ||
| Vol 13, No 3 (2017) | TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 | Abstract similar documents |
| O. M. Drapkina, A. S. Luishuta | ||
| "... Aim. To study the antihypertensive and hypolipidemic effect of therapy based on emperindopril/em ..." | ||
| Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
| D. A. Napalkov, A. V. Zhilenko | ||
| "... adjusting individual treatment depending on clinical conditions. The composition of emperindopril/em ..." | ||
| Vol 15, No 6 (2019) | Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice | Abstract similar documents |
| D. A. Napalkov | ||
| "... of antihypertensive and hypolipidemic therapy with fixed combinations of indapamide/emperindopril/em, amlodipine ..." | ||
| Vol 6, No 2 (2010) | COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION | Abstract similar documents |
| Yu. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova | ||
| "... Aim. To compare efficacy of enalapril and emperindopril/em in patients with arterial hypertension (HT ..." | ||
| Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
| Vol 2, No 2 (2006) | THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM | Abstract similar documents |
| I. G. Fomina, N. A. Galanina, Z. O. Georgadze, N. E. Gaidamakina | ||
| "... Aim. To study the influence of long-term therapy with emperindopril/em on the heart inotropic function ..." | ||
| Vol 5, No 6 (2009) | RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE | Abstract similar documents |
| G. I. Nechaeva, E. N. Loginova | ||
| "... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..." | ||
| Vol 8, No 5 (2012) | ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE | Abstract similar documents |
| M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina | ||
| "... on received drugs: emperindopril/em and ivabradine - group 1; emperindopril/em, bisoprolol and ivabradine - group 2 ..." | ||
| Vol 3, No 4 (2007) | RESULTS AND COMMENTS ON ADVANCE STUDY | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... Влияние сочетанного применения фиксированной комбинации emпериндоприла/em и индапамида на частоту ..." | ||
| Vol 4, No 2 (2008) | ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva | ||
| "... Aim. To study effects of ACE inhibitor emperindopril/em on markers of endothelial dysfunction ..." | ||
| Vol 3, No 1 (2007) | RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY | Abstract similar documents |
| M. L. Maximov | ||
| "... of metoprolol, bisoprolol and emcarvedilol/em had been proven in CHF therapy. Nebivolol was effective in elderly ..." | ||
| Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
| D. B. Nebieridze, A. S. Safaryan | ||
| "... of ACE inhibitors (ramipril, emperindopril/em), which are associated with vasoprotection. ..." | ||
| Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
| D. V. Nebieridze, A. S. Safarian | ||
| "... . However this property can not be extended to all ACE inhibitors. Only ramipril and emperindopril/em have ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
| "... of combined drug of ACE inhibitors and diuretic. 25 patients took NF (emperindopril/em 4 mg and indapamide 1,25 mg ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... displaced the leaders and increased their popularity from 11.3% in 2011-12 to 18.0% in 2013-14 (рem0.01/em ..." | ||
| Vol 5, No 6 (2009) | ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE | Abstract similar documents |
| E. A. Ryabikhin, M. E. Mozheiko | ||
| "... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..." | ||
| Vol 6, No 5 (2010) | WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov | ||
| "... ) — emcarvedilol/em, group 3 (n=30) — nebivolol. Study duration was 6 months. Clinical examination (physical ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... therapy with valsartan (n=20), 80–160 mg/day , or emperindopril/em (n=21), 5–10 mg/day , in combination ..." | ||
| Vol 15, No 2 (2019) | Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice | Abstract similar documents |
| E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova | ||
| "... dose combinations in Vladivostok polyclinics was performed. Two-component (emperindopril/em + amlodipine ..." | ||
| Vol 5, No 5 (2009) | THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
| S. V. Malchikova, E. I. Tarlovskaya | ||
| "... indapamide retard plus emperindopril/em; group B - indapamide retard plus amlodipine; group C - amlodipine plus ..." | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... in patients without left ventricle dysfunction are demonstrated in studies EUROPA with emperindopril/em 8 mg ..." | ||
| Vol 4, No 1 (2008) | VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
| E. D. Golovanova | ||
| "... and emperindopril/em (Noliprel Forte, 1 tab/d: emperindopril/em 4 mg and indapamide 1,25 mg) on pulse wave velocity (PWV ..." | ||
| Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... in groups A, B or C. Patients of group A (n=25) received a fixed combination of the original emperindopril/em ..." | ||
| Vol 16, No 5 (2020) | Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy? | Abstract similar documents |
| Z. D. Kobalava, E. V. Kokhan | ||
| "... combination of indapamide, emperindopril/em and rosuvastatin, the requirements for fixed drug combinations ..." | ||
| Vol 20, No 4 (2024) | BRAНH syndrome: clinical case | Abstract similar documents |
| K. G. Pereverzeva, O. A. Fomina, Yu. S. Batishcheva, L. V. Filippov, S. S. Yakushin | ||
| "... and permanent atrial fibrillation (AF). The patient took emperindopril/em 10 mg, indapamide 2.5 mg, amlodipine 10 mg ..." | ||
| Vol 16, No 3 (2020) | Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction | Abstract similar documents |
| Z. M. Akhilgova, I. I. Almazova, N. K. Gabitova, E. A. Kotaeva, A. G. Avtandilov | ||
| "... Aim. To assess the effect of combination therapy (emperindopril/em, indapamide, amlodipine) on vascular ..." | ||
| Vol 8, No 6 (2012) | MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE | Abstract similar documents |
| V. M. Gorbunov | ||
| "... in patients of amlodipine/emperindopril/em treatment group was significantly lower than this in patients ..." | ||
| Vol 5, No 4 (2009) | TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS | Abstract similar documents |
| S. V. Malchikova, E. I. Tarlovskaya | ||
| "... /emperindopril/em; group B - indapamide retard/amlodipine; group C – amlodipine/lisinopril; group D – amlodipine ..." | ||
| Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
| M. S. Soboleva, Е. E. Loskutova | ||
| "... .6% to 27%), lisinopril (from 4.4% to 23.9%) and emperindopril/em (from 0.9% to 7.8%); among calcium channel ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... the number of recommendations of enalapril increased up to 50.8%, emperindopril/em – up to 24.1%. Analysis ..." | ||
| Vol 5, No 4 (2009) | THE CAMELLIA TRIAL: SCIENTIFIC VALUE AND RECOMMENDS FOR PRACTITIONER | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, S. A. Shalnova, R. G. Oganov | ||
| "... emкарведилоле/em и метопрололе. ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... to moderate DM type 2 were included into the study. The patients were treated with emperindopril/em (5–10 mg/day ..." | ||
| Vol 14, No 5 (2018) | The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness | Abstract similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| "... with SPC (emperindopril/em arginine/indapamide or valsartan/amlodipine) achieved the target BP level (140/90 mm ..." | ||
| Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
| "... . When choosing ACEI, priority was given to emperindopril/em, with which no one randomized clinical trial ..." | ||
| Vol 6, No 2 (2010) | NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER | Abstract similar documents |
| T. Műnzel, T. Gori | ||
| "... рынок США. Как и emкарведилол/em, небиволол относится к третьему поколению β-блокаторов, обладающих наряду с ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... group were older than these in the first group (p0.em001/em). Patients of the group 1 compared to the group ..." | ||
| Vol 17, No 3 (2021) | The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony | Abstract PDF (Eng) similar documents |
| S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... after PCI TSI improved significantly to 163.7±17.6 ms (p0.em001/em), 3 months after PCI showed more ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... (p0.em001/em), they were more often diagnosed with left ventricular aneurysm (p=0.em001/em), chronic kidney ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... ) variability at night (p0.05) and a morning surge in SBP (pem0.01/em), end systolic volume (p0.05), systolic ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.em001/em) with a heredity ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... -diastolic dimension (p0,em001/em), end-systolic dimension (p0,em001/em), left atrium (p=0,004), end-diastolic vol ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p0.em001/em), and flow rate ..." | ||
| Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
| Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... .94%. One month after PCI, mean GLPSS improved significantly to -14.05±1.72% (p0.em001/em), 3 months after PCI ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... : +52.3%, p0.em001/em) in the main cohort and from 12.3% to 19.8% (+61.7%, p0.em001/em) in the additional cohort ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p0.em001/em), and size of the left atrium (LA; from ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... 0.em001/em) were revealed. The right ventricle increased in size with the impairment of its diastolic ..." | ||
| Vol 12, No 6 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.em001/em), the sizes of both atria (p0.em001/em), isovolumic relaxation ..." | ||
| Vol 12, No 1 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.em001/em), the sizes of both atria (p0.em001/em), isovolumic relaxation ..." | ||
| Vol 7, No 5 (2011) | EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. M. Provotorov, S. A. Avdeeva | ||
| "... increase in hemoglobin (+12.5%; p0.em001/em) and hematocrit (+5.8%; p0.em001/em) levels, as well as increase in red ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... in 24 hrs. (from 141.9±1.9 to 128.6±0.8 mmHg, p0.em001/em), in daytime (from 146.8±2.6 to 135.8±1.0 mmHg, p ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.em001/em), as well as the course ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p0.em001/em ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... , only in the main group there was an improvement in all clinical indicators (pem0.01/em), an increase ..." | ||
| Vol 14, No 2 (2018) | SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING | Abstract similar documents |
| E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina | ||
| "... patients (n=84) microlesion count correlated with age (γ=0.243; pem0.01/em), preprocedural hemoglobin level (γ ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... with the frequency of UA control (p0.em001/em). In patients with AH, an increase in the level of sUA was detected ..." | ||
| Vol 19, No 1 (2023) | Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women | Abstract similar documents |
| O. Yu. Isaykina, I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, V. E. Novikov, T. T. Tsoriev | ||
| "... (rs=0.12, p0.05); a more pronounced negative correlation was obtained for BMD (rs=0.16, pem0.01/em ..." | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... . SBP decreased by 37,5 mm Hg (рem0,01/em) in smoking patients and by 37,6 mm Hg (рem0,01/em) in non-smoking ..." | ||
| Vol 6, No 1 (2010) | ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN | Abstract similar documents |
| A. A. Fedorovich, A. N. Rogoza, E. M. Kanisheva, S. A. Boytsov | ||
| "... increased in maximal amplitude endothelial rhythm (at a frequency of em0.01/em Hz) by 76% (p0,em001/em ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS | Abstract similar documents |
| O. L. Barbarash, M. V. Zykov | ||
| "... systolic and diastоlic BP was reduced by 36 and 17 mmHg respectively (р0,em001/em for both), and target BP ..." | ||
| Vol 6, No 4 (2010) | EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA | Abstract similar documents |
| P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev | ||
| "... application led to significant reduction in levels of TC (from 247.1±27 to 186.5±12 mg/dl; p0.em001/em), LDC (from ..." | ||
| Vol 7, No 6 (2011) | EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS | Abstract similar documents |
| V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova | ||
| "... Hg; p0.em001/em; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p0.em001/em ..." | ||
| Vol 6, No 5 (2010) | INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Eng) similar documents |
| E. N. Golovenko, D. A. Napalkov, V. A. Sulimov | ||
| "... (FC) III-IV than in those with CHF of FC I-II (p0.em001/em). Negative correlation was revealed between TrI ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p0.em001/em) and from 6.0±0.7 to 4.1±0.7 mmol/l (p0.em001/em ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... (TTR≥65%) were younger (p0.em001/em), more often men (p0.074) with a high level of education (p0.em001/em ..." | ||
| Vol 8, No 2 (2012) | SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS | Abstract similar documents |
| I. S. Dzherieva, N. I. Volkova, S. I. Rapoport | ||
| "... higher than that in employees with steady work schedule (34.4 vs 27.4%, respectively; рem0.01/em ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... , triglyceride (p0.em001/em) and significant increase in high-density lipoprotein cholesterol (p0.em001/em) when compared ..." | ||
| Vol 16, No 5 (2020) | Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation | Abstract similar documents |
| M. G. Bubnova, D. M. Aronov | ||
| "... of physical training in patients with AF after RFA: increase in exercise duration by 18.6% (p0.em001/em) and load ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... was 39.3% higher (p=0.em001/em), interleukin-10 – 20.2% higher (p=em0.01/em), superoxide dismutase – 78.9% higher ..." | ||
| Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
| I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
| "... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.em001/em), ST segment elevation in lead III (9 ..." | ||
| 1 - 100 of 348 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
